vs

Side-by-side financial comparison of Bumble Inc. (BMBL) and INTEGRA LIFESCIENCES HOLDINGS CORP (IART). Click either name above to swap in a different company.

INTEGRA LIFESCIENCES HOLDINGS CORP is the larger business by last-quarter revenue ($434.9M vs $224.2M, roughly 1.9× Bumble Inc.). On growth, INTEGRA LIFESCIENCES HOLDINGS CORP posted the faster year-over-year revenue change (-1.7% vs -14.3%). Over the past eight quarters, INTEGRA LIFESCIENCES HOLDINGS CORP's revenue compounded faster (8.6% CAGR vs -8.5%).

Bumble is a mobile app for online dating and social networking. It was founded by Whitney Wolfe Herd and was launched in December 2014. Bumble is operated by Bumble Inc., which also owns Badoo.

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.

BMBL vs IART — Head-to-Head

Bigger by revenue
IART
IART
1.9× larger
IART
$434.9M
$224.2M
BMBL
Growing faster (revenue YoY)
IART
IART
+12.6% gap
IART
-1.7%
-14.3%
BMBL
Faster 2-yr revenue CAGR
IART
IART
Annualised
IART
8.6%
-8.5%
BMBL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BMBL
BMBL
IART
IART
Revenue
$224.2M
$434.9M
Net Profit
$-490.2M
Gross Margin
71.2%
50.8%
Operating Margin
-256.8%
5.3%
Net Margin
-218.7%
Revenue YoY
-14.3%
-1.7%
Net Profit YoY
-11829.5%
EPS (diluted)
$-3.96
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMBL
BMBL
IART
IART
Q4 25
$224.2M
$434.9M
Q3 25
$246.2M
$402.1M
Q2 25
$248.2M
$415.6M
Q1 25
$247.1M
$382.7M
Q4 24
$261.6M
$442.6M
Q3 24
$273.6M
$380.8M
Q2 24
$268.6M
$418.2M
Q1 24
$267.8M
$368.9M
Net Profit
BMBL
BMBL
IART
IART
Q4 25
$-490.2M
Q3 25
$37.3M
$-5.4M
Q2 25
$-253.7M
$-484.1M
Q1 25
$13.4M
$-25.3M
Q4 24
$4.2M
Q3 24
$-613.2M
$-10.7M
Q2 24
$27.4M
$-12.4M
Q1 24
$24.6M
$-3.3M
Gross Margin
BMBL
BMBL
IART
IART
Q4 25
71.2%
50.8%
Q3 25
71.9%
51.5%
Q2 25
70.1%
50.4%
Q1 25
70.3%
50.8%
Q4 24
56.3%
Q3 24
52.6%
Q2 24
54.0%
Q1 24
99.1%
56.1%
Operating Margin
BMBL
BMBL
IART
IART
Q4 25
-256.8%
5.3%
Q3 25
25.9%
2.9%
Q2 25
-136.3%
-123.4%
Q1 25
18.1%
-4.0%
Q4 24
14.1%
8.0%
Q3 24
-306.3%
-2.1%
Q2 24
19.3%
-0.7%
Q1 24
18.2%
1.1%
Net Margin
BMBL
BMBL
IART
IART
Q4 25
-218.7%
Q3 25
15.2%
-1.3%
Q2 25
-102.2%
-116.5%
Q1 25
5.4%
-6.6%
Q4 24
1.6%
Q3 24
-224.1%
-2.8%
Q2 24
10.2%
-3.0%
Q1 24
9.2%
-0.9%
EPS (diluted)
BMBL
BMBL
IART
IART
Q4 25
$-3.96
$-0.03
Q3 25
$0.33
$-0.07
Q2 25
$-2.45
$-6.31
Q1 25
$0.13
$-0.33
Q4 24
$0.09
$0.25
Q3 24
$-5.11
$-0.14
Q2 24
$0.22
$-0.16
Q1 24
$0.19
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMBL
BMBL
IART
IART
Cash + ST InvestmentsLiquidity on hand
$175.8M
$263.7M
Total DebtLower is stronger
$590.6M
$726.6M
Stockholders' EquityBook value
$570.0M
$1.0B
Total Assets
$1.4B
$3.6B
Debt / EquityLower = less leverage
1.04×
0.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMBL
BMBL
IART
IART
Q4 25
$175.8M
$263.7M
Q3 25
$307.9M
$267.9M
Q2 25
$261.7M
$253.6M
Q1 25
$202.2M
$273.3M
Q4 24
$204.3M
$273.6M
Q3 24
$252.1M
$277.6M
Q2 24
$286.7M
$296.9M
Q1 24
$262.7M
$663.1M
Total Debt
BMBL
BMBL
IART
IART
Q4 25
$590.6M
$726.6M
Q3 25
$736.3M
Q2 25
$745.9M
Q1 25
$755.6M
Q4 24
$621.3M
$760.5M
Q3 24
$765.3M
Q2 24
$770.2M
Q1 24
$775.0M
Stockholders' Equity
BMBL
BMBL
IART
IART
Q4 25
$570.0M
$1.0B
Q3 25
$675.5M
$1.0B
Q2 25
$577.6M
$1.0B
Q1 25
$814.5M
$1.5B
Q4 24
$824.5M
$1.5B
Q3 24
$852.6M
$1.5B
Q2 24
$1.7B
$1.5B
Q1 24
$1.6B
$1.6B
Total Assets
BMBL
BMBL
IART
IART
Q4 25
$1.4B
$3.6B
Q3 25
$2.2B
$3.6B
Q2 25
$2.2B
$3.7B
Q1 25
$2.5B
$4.1B
Q4 24
$2.5B
$4.0B
Q3 24
$2.6B
$4.1B
Q2 24
$3.5B
$4.1B
Q1 24
$3.5B
$4.1B
Debt / Equity
BMBL
BMBL
IART
IART
Q4 25
1.04×
0.70×
Q3 25
0.71×
Q2 25
0.72×
Q1 25
0.50×
Q4 24
0.75×
0.49×
Q3 24
0.50×
Q2 24
0.50×
Q1 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMBL
BMBL
IART
IART
Operating Cash FlowLast quarter
$59.1M
$11.8M
Free Cash FlowOCF − Capex
$-5.4M
FCF MarginFCF / Revenue
-1.2%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMBL
BMBL
IART
IART
Q4 25
$59.1M
$11.8M
Q3 25
$76.8M
$40.9M
Q2 25
$71.2M
$8.9M
Q1 25
$43.2M
$-11.3M
Q4 24
$-5.4M
$50.7M
Q3 24
$93.5M
$22.5M
Q2 24
$32.9M
$40.4M
Q1 24
$2.4M
$15.8M
Free Cash Flow
BMBL
BMBL
IART
IART
Q4 25
$-5.4M
Q3 25
$25.8M
Q2 25
$-11.2M
Q1 25
$-40.2M
Q4 24
$21.1M
Q3 24
$-7.2M
Q2 24
$10.7M
Q1 24
$291.0K
FCF Margin
BMBL
BMBL
IART
IART
Q4 25
-1.2%
Q3 25
6.4%
Q2 25
-2.7%
Q1 25
-10.5%
Q4 24
4.8%
Q3 24
-1.9%
Q2 24
2.6%
Q1 24
0.1%
Capex Intensity
BMBL
BMBL
IART
IART
Q4 25
4.0%
Q3 25
3.8%
Q2 25
4.8%
Q1 25
7.6%
Q4 24
6.7%
Q3 24
7.8%
Q2 24
7.1%
Q1 24
4.2%
Cash Conversion
BMBL
BMBL
IART
IART
Q4 25
Q3 25
2.06×
Q2 25
Q1 25
3.22×
Q4 24
-1.29×
Q3 24
Q2 24
1.20×
Q1 24
0.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMBL
BMBL

Bumble App$181.0M81%
Badoo App And Other$43.2M19%

IART
IART

Neurosurgery$226.2M52%
Asia Pacific$53.7M12%
Instruments$52.3M12%
ENT$44.8M10%
Other$38.9M9%
Rest Of The World$19.0M4%

Related Comparisons